missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human CX3CL1/Fractalkine (Full Length) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marke: R&D Systems™ 365-FR-025
Weitere Details : Netto-Gewicht : 0.00970kg
Beschreibung
The Recombinant Human CX3CL1/Fractalkine (Full Length) Protein is derived from NS0. The Recombinant Human CX3CL1/Fractalkine (Full Length) Protein has been validated for the following applications: Bioactivity.Spezifikation
| Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
| 35 kDa | |
| 25μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
| 6376 | |
| CX3CL1/Fractalkine Full Length | |
| Mouse myeloma cell line,NS0-derived human CX3CL1/Fractalkine protein, (N-terminus) Human CX3CL 1 (Gln25-Arg339) (Ser199Asn) Accession &Num; P78423 KQN 6-His tag (C-terminus) | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |